Cryopreservation is a key step for
current translational medicine
including reproductive medicine, regenerative medicine, and cell therapy.
However, it is challenging to preserve rare cells for practical applications
due to the difficulty in handling low numbers of cells as well as
the lack of highly efficient and biocompatible preservation protocols.
Here, we developed an acoustic droplet vitrification method for high-efficiency
handling and preservation of rare cells. By employing an acoustic
droplet ejection device, we can encapsulate rare cells into water-in-air
droplets with a volume from ∼pL to ∼nL and deposit these
cell-containing droplets into a droplet array onto a substrate. By
incorporating a cooling system into the droplet array substrate, we
can vitrify hundreds to thousands of rare cells at an ultrafast speed
(about ∼2 s) based on the high surface to volume ratio of the
droplets. By optimizing this method with three different cell lines
(a human lung cancer cell line, A549 cells, a human liver cell line,
L02 cells, and a mouse embryonic fibroblast cell line, 3T3-L1 cells),
we developed an effective protocol with excellent cell viability (e.g.,
>85% for days, >70% for months), proliferation, and adhesion.
As a
proof-of-concept application, we demonstrated that our method can
rapidly handle and efficiently preserve rare cells, highlighting its
broad applications in species diversity, basic research, and clinical
medicine.